Cargando…
Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial Virus
BACKGROUND: Bronchiolitis caused by the respiratory syncytial virus (RSV) in infants less than two years old is a growing public health concern worldwide, and there is currently no safe and effective vaccine. A major component of RSV nucleocapsid, the nucleoprotein (N), has been so far poorly explor...
Autores principales: | Roux, Xavier, Dubuquoy, Catherine, Durand, Guillaume, Tran-Tolla, Thi-Lan, Castagné, Nathalie, Bernard, Julie, Petit-Camurdan, Agnès, Eléouët, Jean-François, Riffault, Sabine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262139/ https://www.ncbi.nlm.nih.gov/pubmed/18335041 http://dx.doi.org/10.1371/journal.pone.0001766 |
Ejemplares similares
-
A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus
por: Riffault, Sabine, et al.
Publicado: (2010) -
Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine
por: Remot, Aude, et al.
Publicado: (2012) -
Structural landscape of the respiratory syncytial virus nucleocapsids
por: Gonnin, Lorène, et al.
Publicado: (2023) -
Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis
por: Jacque, Emilie, et al.
Publicado: (2021) -
The respiratory syncytial virus nucleoprotein–RNA complex forms a left-handed helical nucleocapsid
por: Bakker, Saskia E., et al.
Publicado: (2013)